THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for non-Hodgkin’s lymphoma in elderly patients: a prospective study

@article{Niitsu1997THPCOPBLMC,
  title={THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for non-Hodgkin’s lymphoma in elderly patients: a prospective study},
  author={Nozomi Niitsu and Masanori Umeda},
  journal={Leukemia},
  year={1997},
  volume={11},
  pages={1817-1820}
}
THP-COPBLM including pirarubicin (THP) , which is thought to be less toxic than doxorubicin, was used to treat non- Hodgkin’s lymphoma (NHL) and the remission rate and adverse effects were studied in 26 patients older than 70 years. Complete remission (CR) was achieved in 19 patients (73.1%) and partial remission in three (11.5%). Classified by stages, CR… CONTINUE READING